(Q43574521)

24 November 2017

title

Signaling antibodies complexed with adenovirus circumvent CAR and integrin interactions and improve gene delivery (English)

1 reference

24 November 2017

1 reference

1 reference

Li E

1

1 reference

24 November 2017

Brown SL

2

1 reference

24 November 2017

Von Seggern DJ

3

1 reference

24 November 2017

Brown GB

4

1 reference

24 November 2017

Nemerow GR

5

1 reference

24 November 2017

publication date

1 September 2000

1 reference

24 November 2017

1 reference

24 November 2017

volume

7

1 reference

24 November 2017

issue

18

1 reference

24 November 2017

page(s)

1593-1599

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.gt.3301271

24 November 2017

exact match

0 references

cites work

Gene therapy for cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301271

Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301271

HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301271

Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301271

Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301271

Inefficient gene transfer by adenovirus vector to cystic fibrosis airway epithelia of mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301271

The 'adenobody' approach to viral targeting: specific and enhanced adenoviral gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301271

Targeted gene delivery by tropism-modified adenoviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301271

Adenovirus targeted to heparan-containing receptors increases its gene delivery efficiency to multiple cell types

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301271

Integrin-linked kinase (ILK): a regulator of integrin and growth-factor signalling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301271

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301271

Tumor necrosis factor alpha inhibits signaling from the insulin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301271

Tumor necrosis factor promotes phosphorylation and binding of insulin receptor substrate 1 to phosphatidylinositol 3-kinase in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301271

Interaction of phosphatidylinositol 3-kinase-associated p85 with epidermal growth factor and platelet-derived growth factor receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301271

Cryo-EM visualization of an exposed RGD epitope on adenovirus that escapes antibody neutralization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301271

Involvement of integrin alpha V gene expression in human melanoma tumorigenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301271

AlphaVbeta5 integrin: a co-receptor for adeno-associated virus type 2 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301271

Intracellular pathogens and the actin cytoskeleton

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301271

A novel and rapid cloning method for the T-cell receptor variable region sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301271

Genetic engineering of a recombinant fusion possessing anti-tumor F(ab')2 and tumor necrosis factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301271

Targeted adenoviral vectors for cancer gene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301271

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.GT.3301271

1 reference

7 January 2021

Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301271

7 January 2021

Expression of alpha v beta 5 integrin is necessary for efficient adenovirus-mediated gene transfer in the human airway.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301271

7 January 2021

Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301271

7 January 2021

Ultrastructural and immunofluorescence studies of early events in adenovirus-HeLa cell interactions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301271

7 January 2021

Adenovirus endocytosis via alpha(v) integrins requires phosphoinositide-3-OH kinase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301271

7 January 2021

Effects of growth factors on phosphatidylinositol-3 kinase in astroglial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301271

7 January 2021

Interactions of soluble recombinant integrin alphav beta5 with human adenoviruses.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301271

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3301271

1 reference

Dimensions Publication ID

24 November 2017

1032823465

0 references

1 reference